Outlook for 2017: Myeloma, Lymphoma, and MPNs
This look ahead at hematologic malignancies in 2017 focuses on new agents being studied for the treatment of multiple myeloma, Hodgkin lymphoma, non-Hodgkin lymphoma, and myeloproliferative neoplasms.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Amrita Y. Krishnan, MD David Snyder, MD Robert Chen, MD Tanya Siddiqi, MD Tags: Conferences/Hematologic Malignancies Year in Review 2016 Source Type: news
More News: Cancer & Oncology | Conferences | Hematology | Lymphoma | Myeloma | Myeloproliferative Disorders | Non-Hodgkin's Lymphoma